Navigation Links
Simbionix Welcomes Two New Members to Expand Compay's Medical Education Product Offerings
Date:6/16/2010

CLEVELAND, Ohio, June 16, 2010 /PRNewswire/ -- Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, is pleased to announce that Marc Schwachter M.D., and Paul DeLuca have joined the Company's Medical Education Division (MED).

Marc Schwachter, M.D. has joined Simbionix as Physician Community Manager for MED. Marc will be responsible for developing training programs, educational content, and services supporting the Company's virtual reality simulators and case-based physician training. In this role he will be the Company's authority on how surgeons, medical practitioners, and healthcare professionals learn, practice, and stay current with the latest medical procedures, practices, and technology.

Marc graduated from University of Vermont with a degree in Zoology/Philosophy and has a M.D. from Case Western Reserve University School of Medicine. He did his Residency in Obstetrics and Gynecology at the University of Illinois Department of OB/GYN. Prior to accepting this position, Marc worked with University Hospitals Department of Surgery in Cleveland, OH to deliver surgical skills training and create a surgical video repository to foster the growth of the department as a leader in surgical teaching. He designed and produced innovative teaching techniques including international webinars, live surgical symposiums and online consulting and conferencing for the surgeons.

"Marc's passion for medicine, training and technology is contagious," said Paul Jensen, General Manager of Simbionix Medical Education Division. "I'm confident that Marc will be a tremendous asset to the MED team and Simbionix."

Paul DeLuca will be responsible for the new product development process to define, build and launch the product platform to support the MED business strategy. Amongst his activities, Paul will conduct market research to specify market requirements, maintain the product roadmap illustrating the vision and key phases of delivery for the platform, and develop and implement the marketing strategy.

Paul brings strong experience in technology product development and innovative new-media marketing. Prior to accepting this position, he was Director of Marketing & Web Services with Centric Technologies where he managed the design, development, hosting, and technical maintenance of dozens of commercial web sites. Following the acquisition of MCI Telecommunications' internet business by Cable & Wireless Global PLC, he was the Director of Global Web Hosting Product Management, leading a team of product managers in developing 4 web hosting/content management products that generated over $52 million in global web hosting revenue.

"Paul's strengths and experiences are an excellent match for this position and Simbionix is fortunate to have him on the team," said Paul Jensen.

About Simbionix USA Corporation

Simbionix is the world's leading provider of simulation and training products for medical professionals and the healthcare industry. Founded in 1997, the company is committed to delivering high quality products, advancing clinical performance and optimizing procedural outcomes. Simbionix cooperates with physicians on a regular basis to produce the most reliable and effective training and supporting systems.

For more information on Simbionix, visit http://www.simbionix.com

Contact: Rebecca@simbionix.com, +972-54-8050427


'/>"/>
SOURCE Simbionix Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries
2. Simbionix Introduces the Next Generation in Bronchoscopy Training
3. Michigan Catholic Conference Welcomes Announcement of Non-Embryo Destructive Stem Cell Research Advancement
4. Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine
5. Boston Scientific Welcomes Results of Brain Aneurysm Clinical Trial
6. EP Global Communications, Inc. Welcomes Stephen DeFelice, MD, to Advisory Board
7. Pinstripe Welcomes Carrie Harris-Muller To Board
8. National Pharmaceutical Council Welcomes New Member, Otsuka America Pharmaceutical, Inc.
9. Leading Denture Cream Litigation Firm Welcomes GSK Announcement of Removal of Zinc From Its Denture Creams
10. International Medical Corps Matched with Top 25 American Express Members Project, Saving the Lives of Malnourished Children
11. Ocular Therapeutix, Inc. Appoints Two New Board Members
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016  MedSource announced today ... its e-clinical software solution of choice.  This latest ... possible value to their clients by offering a ... preferred relationship establishes nowEDC as the EDC platform ... MedSource,s full-service clients.  "nowEDC has long been a ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
(Date:6/23/2016)... Calif. , June 23, 2016 ... CST on Thursday, July 7, 2016 , , , , ... ) , , , , EXPERT PANELISTS:  , , ... Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar ... The global pharmaceutical industry is witnessing an exceptional ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
Breaking Medicine News(10 mins):